Five Common Misinterpretations of P‑Values in Medical Research

Why does a single number on a table sometimes feel like a verdict? In the past year I’ve watched grant reviewers stare at p‑values the way a detective watches a fingerprint—sometimes convinced it tells the whole story, other times dismissing a study because the number didn’t cross an arbitrary line. The truth sits somewhere in the middle, and misunderstanding p‑values can steer a trial from promising to pointless. Let’s untangle the most frequent myths before they steer your next protocol off course.

What a p‑value actually is (and isn’t)

Before we dive into the myths, a quick refresher. In plain language, a p‑value answers the question: If the null hypothesis were true, how likely would we observe data at least as extreme as what we actually saw? The null hypothesis is the default assumption—usually that there is no difference between treatment and control. A small p‑value means the observed data would be unlikely under that assumption; it does not prove the alternative hypothesis, nor does it measure the size or importance of an effect.

Think of it like a courtroom scenario. The null hypothesis is the presumption of innocence. A low p‑value is akin to a piece of evidence that makes innocence seem improbable, but it’s not a full confession.

Misinterpretation #1 – “p < 0.05 proves the treatment works”

The most entrenched myth is that crossing the 0.05 threshold is a stamp of efficacy. In reality, a p‑value of 0.04 simply says, “If there truly were no effect, there’s a 4 % chance we’d see data this extreme.” It says nothing about clinical relevance, safety, or reproducibility. I once reviewed a phase II trial where the primary endpoint had p = 0.049. The sponsor celebrated a breakthrough, yet the effect size was a modest 2 % improvement—hardly worth the cost of a phase III rollout. Statistical significance is a signal; it still needs context, magnitude, and biological plausibility.

Misinterpretation #2 – “A non‑significant p‑value means no effect”

The flip side of the coin is equally dangerous. A p‑value of 0.27 does not prove that the treatment does nothing; it merely indicates that the data we have are insufficient to rule out the null hypothesis. Small sample sizes, high variability, or a modest true effect can all produce non‑significant results. In my own work on a rare autoimmune disease, we stopped a promising candidate after a single under‑powered study reported p = 0.12. A later, larger trial revealed a clear benefit. The lesson? Treat non‑significance as “inconclusive,” not “negative.”

Misinterpretation #3 – “The p‑value tells me the probability the hypothesis is true”

A classic confusion is to read the p‑value as the probability that the null hypothesis is true. It is not. The p‑value is calculated assuming the null hypothesis is true; it does not flip the conditional. Bayesian statistics can give you a probability that a hypothesis is true, but that requires a prior distribution—something the frequentist p‑value deliberately avoids. When I explain this to clinicians, I liken it to weather forecasts: a 30 % chance of rain does not mean it will rain 30 % of the time; it means that, given past patterns, rain occurs on 30 % of days with similar conditions.

Misinterpretation #4 – “The smaller the p‑value, the stronger the evidence”

While a p‑value of 0.001 is more surprising under the null than 0.04, the relationship is not linear, and the magnitude of the p‑value does not translate directly into evidence strength. Moreover, p‑values are sensitive to sample size. With a huge cohort, even trivial differences can yield p = 0.0001, yet the clinical impact may be negligible. Conversely, a p‑value of 0.06 in a small pilot study could reflect a genuinely important effect that simply needs more data. Always pair the p‑value with effect size, confidence intervals, and a realistic appraisal of what the difference means for patients.

Misinterpretation #5 – “If I adjust the analysis, the p‑value will magically become significant”

Data dredging, or “p‑hacking,” is the practice of trying multiple analyses until something crosses the 0.05 line. Adjusting for multiple comparisons (e.g., using Bonferroni correction) is a legitimate safeguard, but it does not rescue a study that was designed without a clear hypothesis. I recall a colleague who, after a series of exploratory subgroup analyses, reported a p‑value of 0.03 for a secondary endpoint. The journal required a correction for the dozens of tests performed, and the adjusted p‑value ballooned to 0.45. The takeaway: pre‑specify your primary outcomes, limit the number of looks at the data, and be transparent about any post‑hoc explorations.

How to use p‑values responsibly

Report the exact value – Don’t just say “p < 0.05.” Provide the number to two decimal places; readers can judge the strength themselves.
Show confidence intervals – They convey the range of plausible effect sizes and are far more informative than a binary “significant/not significant” label.
Contextualize – Discuss biological plausibility, prior evidence, and clinical relevance alongside the statistical test.
Pre‑register – Register your primary endpoints and analysis plan before data collection. This reduces the temptation to chase significance after the fact.
Educate the team – Make sure everyone from the statistician to the principal investigator understands what a p‑value can and cannot tell you. A shared language prevents misinterpretation from creeping into grant proposals and press releases.

A personal note

When I first earned my doctorate, I was dazzled by the elegance of a p‑value that fell just below 0.05. I celebrated like I had cracked the code of disease. Years later, after seeing a colleague’s enthusiastic press release turn into a costly phase III failure, I learned humility. Statistics are a tool, not a crystal ball. The most rewarding studies I’ve been part of were those where the numbers sparked curiosity, not complacency—prompting us to ask “why?” and “what next?” rather than “we’ve won.”

In the end, the p‑value is a compass, not a map. Use it wisely, and it will guide you toward robust, reproducible science. Misinterpret it, and you may find yourself navigating a dead‑end.